Funds holding Trevi Therapeutics Inc
ISIN US89532M1018 · United States
- Fund holders
- 166
- Of which ETFs
- 31 135 other funds
- Value held
- ≈ 401.3M $ 400.4M $ · 734.2K €
- Share of capital
- 22.6 % of 142.5M shares on Jul 31, 2026
| Fund | Shares | Value | Weight in fund | Share of capital | |
|---|---|---|---|---|---|
| 1290 VT Micro Cap Portfolio EQ Advisors Trust | 17,015 | 203K $ | 0.12 % | 0.01 % | as of Mar 31, 2026 ↗ |
| SIIT EXTENDED MARKET INDEX FUND SEI INSTITUTIONAL INVESTMENTS TRUST | 16,200 | 193.1K $ | 0.02 % | 0.01 % | as of Feb 28, 2026 ↗ |
| PROFUND VP PHARMACEUTICALS ProFunds | 15,686 | 187.1K $ | 1.84 % | 0.01 % | as of Mar 31, 2026 ↗ |
| Fidelity Flex Small Cap Index Fund Fidelity Salem Street Trust | 15,643 | 215.2K $ | 0.05 % | 0.01 % | as of Apr 30, 2026 ↗ |
| iShares Russell Small/Mid-Cap Index Fund BlackRock Funds | 15,184 | 208.9K $ | 0.02 % | 0.01 % | as of Apr 30, 2026 ↗ |
| Direxion Daily Pharmaceutical & Medical Bull 3X Shares Direxion Shares ETF Trust | 14,451 | 198.8K $ | 1.54 % | 0.01 % | as of Apr 30, 2026 ↗ |
| DWS Small Cap Index VIP DEUTSCHE DWS INVESTMENTS VIT FUNDS | 13,378 | 159.6K $ | 0.04 % | 0.01 % | as of Mar 31, 2026 ↗ |
| ACUITAS US MICROCAP FUND FORUM FUNDS II | 13,180 | 157.2K $ | 0.16 % | 0.01 % | as of Mar 31, 2026 ↗ |
| EQ/Morgan Stanley Small Cap Growth Portfolio EQ Advisors Trust | 13,037 | 155.5K $ | 0.04 % | 0.01 % | as of Mar 31, 2026 ↗ |
| New Covenant Growth Fund NEW COVENANT FUNDS | 11,314 | 135K $ | 0.03 % | 0.01 % | as of Mar 31, 2026 ↗ |
| BlackRock Small Cap Index V.I. Fund BlackRock Variable Series Funds, Inc. | 11,294 | 134.7K $ | 0.04 % | 0.01 % | as of Mar 31, 2026 ↗ |
| AVIP BlackRock Advantage Small Cap Growth Portfolio AuguStar Variable Insurance Products Fund Inc | 11,074 | 132.1K $ | 0.11 % | 0.01 % | as of Mar 31, 2026 ↗ |
| T. Rowe Price Small-Cap Index Fund T. ROWE PRICE INDEX TRUST, INC. | 10,897 | 130K $ | 0.04 % | 0.01 % | as of Mar 31, 2026 ↗ |
| Goldman Sachs Absolute Return Tracker Fund GOLDMAN SACHS TRUST | 10,265 | 122.5K $ | 0.00 % | 0.01 % | as of Mar 31, 2026 ↗ |
| SA Small Cap Index Portfolio SUNAMERICA SERIES TRUST | 10,260 | 141.2K $ | 0.04 % | 0.01 % | as of Apr 30, 2026 ↗ |
| Voya RussellTM Small Cap Index Portfolio Voya VARIABLE PORTFOLIOS INC | 9,735 | 116.1K $ | 0.03 % | 0.01 % | as of Mar 31, 2026 ↗ |
| Victory Extended Market Index Fund Victory Portfolios III | 9,427 | 129.7K $ | 0.02 % | 0.01 % | as of Apr 30, 2026 ↗ |
| Nationwide Small Cap Index Fund Nationwide Mutual Funds | 7,854 | 108.1K $ | 0.04 % | 0.01 % | as of Apr 30, 2026 ↗ |
| CVT Russell 2000 Small Cap Index Portfolio Calvert Variable Trust, Inc. | 7,632 | 91K $ | 0.04 % | 0.01 % | as of Mar 31, 2026 ↗ |
| VANGUARD RUSSELL 3000 INDEX FUND VANGUARD SCOTTSDALE FUNDS | 7,612 | 90.7K $ | 0.00 % | 0.01 % | as of Feb 28, 2026 ↗ |
| Invesco Nasdaq Biotechnology ETF Invesco Exchange-Traded Fund Trust II | 7,146 | 85.2K $ | 0.11 % | 0.01 % | as of Feb 28, 2026 ↗ |
| PD Small-Cap Growth Index Portfolio PACIFIC SELECT FUND | 7,085 | 84.5K $ | 0.07 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Venerable Small Cap Index Fund Venerable Variable Insurance Trust | 7,034 | 83.9K $ | 0.04 % | 0.00 % | as of Mar 31, 2026 ↗ |
| VIP Extended Market Index Portfolio Variable Insurance Products Fund II | 7,031 | 83.9K $ | 0.02 % | 0.00 % | as of Mar 31, 2026 ↗ |
| iShares MSCI World Small-Cap ETF iShares Trust | 6,855 | 81.7K $ | 0.01 % | 0.00 % | as of Feb 28, 2026 ↗ |
| Strategic Equity Allocation Trust John Hancock Variable Insurance Trust | 6,676 | 79.6K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| iShares Total U.S. Stock Market Index Fund BlackRock Funds | 6,134 | 84.4K $ | 0.00 % | 0.00 % | as of Apr 30, 2026 ↗ |
| ProShares Ultra Nasdaq Biotechnology ProShares Trust | 5,921 | 70.6K $ | 0.08 % | 0.00 % | as of Feb 28, 2026 ↗ |
| Voya VACS Index Series SC Portfolio Voya VARIABLE PORTFOLIOS INC | 5,647 | 67.4K $ | 0.04 % | 0.00 % | as of Mar 31, 2026 ↗ |
| ProShares Ultra Russell2000 ProShares Trust | 5,625 | 67.1K $ | 0.02 % | 0.00 % | as of Feb 28, 2026 ↗ |
| ProShares UltraPro Russell2000 ProShares Trust | 5,609 | 66.9K $ | 0.02 % | 0.00 % | as of Feb 28, 2026 ↗ |
| U.S. Small Cap Equity Fund RUSSELL INVESTMENT FUNDS | 5,366 | 64K $ | 0.03 % | 0.00 % | as of Mar 31, 2026 ↗ |
| iShares Morningstar Small-Cap ETF iShares Trust | 4,959 | 68.2K $ | 0.03 % | 0.00 % | as of Apr 30, 2026 ↗ |
| Morgan Stanley Pathway Small-Mid Cap Equity ETF MORGAN STANLEY PATHWAY FUNDS | 4,061 | 48.4K $ | 0.01 % | 0.00 % | as of Feb 28, 2026 ↗ |
| ProShares Russell 2000 High Income ETF ProShares Trust | 3,935 | 46.9K $ | 0.03 % | 0.00 % | as of Feb 28, 2026 ↗ |
| PHARMACEUTICALS ULTRASECTOR PROFUND ProFunds | 3,718 | 51.2K $ | 1.52 % | 0.00 % | as of Apr 30, 2026 ↗ |
| Multimanager Aggressive Equity Portfolio EQ Advisors Trust | 3,700 | 44.1K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| EQ/Franklin Small Cap Value Managed Volatility Portfolio EQ Advisors Trust | 2,870 | 34.2K $ | 0.01 % | 0.00 % | as of Mar 31, 2026 ↗ |
| VIP Total Market Index Portfolio Variable Insurance Products Fund II | 2,480 | 29.6K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Fidelity Small Cap Stock K6 Fund Fidelity Concord Street Trust | 2,405 | 33.1K $ | 0.18 % | 0.00 % | as of Apr 30, 2026 ↗ |
| Victory Science & Technology Fund Victory Portfolios III | 2,379 | 32.7K $ | 0.00 % | 0.00 % | as of Apr 30, 2026 ↗ |
| Penn Series Small Cap Index Fund Penn Series Funds Inc | 2,375 | 28.3K $ | 0.04 % | 0.00 % | as of Mar 31, 2026 ↗ |
| BlackRock Advantage SMID Cap V.I. Fund BlackRock Variable Series Funds, Inc. | 2,306 | 27.5K $ | 0.02 % | 0.00 % | as of Mar 31, 2026 ↗ |
| State Street Total Return V.I.S. Fund STATE STREET VARIABLE INSURANCE SERIES FUNDS INC | 2,131 | 25.4K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Total Stock Market Index Trust John Hancock Variable Insurance Trust | 2,067 | 24.7K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Destinations Small-Mid Cap Equity Fund Brinker Capital Destinations Trust | 2,045 | 24.4K $ | 0.00 % | 0.00 % | as of Feb 28, 2026 ↗ |
| TIAA Separate Account VA-1 - Stock Index Account TIAA Separate Account VA-1 | 1,838 | 21.9K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Nationwide Fundamental All Cap Equity Portfolio Nationwide Mutual Funds | 1,753 | 24.1K $ | 0.00 % | 0.00 % | as of Apr 30, 2026 ↗ |
| Fidelity Flex Small Cap Focused Index Fund Fidelity Salem Street Trust | 1,257 | 17.3K $ | 0.11 % | 0.00 % | as of Apr 30, 2026 ↗ |
| ULTRA SMALL CAP PROFUND ProFunds | 1,077 | 14.8K $ | 0.03 % | 0.00 % | as of Apr 30, 2026 ↗ |
| Nuveen Life Stock Index Fund TIAA-CREF Life Funds | 983 | 11.7K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Knights of Columbus U.S. ALL CAP INDEX FUND ADVISORS' INNER CIRCLE III | 606 | 8.3K $ | 0.00 % | 0.00 % | as of Apr 30, 2026 ↗ |
| Wilshire 5000 Index Fund Wilshire Mutual Funds Inc | 555 | 6.6K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Russell 2000 2x Strategy Fund Rydex Dynamic Funds | 451 | 5.4K $ | 0.01 % | 0.00 % | as of Mar 31, 2026 ↗ |
| State Street Balanced Index Fund STATE STREET INSTITUTIONAL INVESTMENT TRUST | 361 | 4.3K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| PROFUND VP ULTRA SMALL CAP ProFunds | 320 | 3.8K $ | 0.02 % | 0.00 % | as of Mar 31, 2026 ↗ |
| PROFUND VP SMALL CAP ProFunds | 242 | 2.9K $ | 0.02 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Russell 2000 Fund Rydex Series Funds | 207 | 2.5K $ | 0.02 % | 0.00 % | as of Mar 31, 2026 ↗ |
| SMALL-CAP PROFUND ProFunds | 174 | 2.4K $ | 0.03 % | 0.00 % | as of Apr 30, 2026 ↗ |
| Russell 2000 1.5x Strategy Fund Rydex Series Funds | 124 | 1.5K $ | 0.02 % | 0.00 % | as of Mar 31, 2026 ↗ |
| ProShares Hedge Replication ETF ProShares Trust | 93 | 1.1K $ | 0.00 % | 0.00 % | as of Feb 28, 2026 ↗ |
| ProShares Russell 2000 Dynamic Buffer ETF ProShares Trust | 28 | 333.8 $ | 0.03 % | 0.00 % | as of Feb 28, 2026 ↗ |
| Russell 2000(R) 1.5x Strategy Fund Rydex Variable Trust | 24 | 286.3 $ | 0.01 % | 0.00 % | as of Mar 31, 2026 ↗ |
| U.S. SMALL CAP PORTFOLIO DFA INVESTMENT DIMENSIONS GROUP INC | 16 | 220.2 $ | 0.00 % | as of Apr 30, 2026 ↗ | |
| VIFAG 2002, SICAV S.A. GESALCALA, S.A., S.G.I.I.C. | 710.3K € | 0.86 % | as of Dec 31, 2025 ↗ | ||
| A&P LIFESCIENCE FUND, FI WELZIA MANAGEMENT, SGIIC, S.A. | 23.9K € | 0.65 % | as of Dec 31, 2025 ↗ |
The funds most exposed to it
The weight is the share of a fund's net assets. The holders table ranks funds by number of shares. This one ranks them by the weight of the company in each fund.
| Fund | Weight in fund | |
|---|---|---|
| F/m Emerald Life Sciences Innovation ETF RBB Fund, Inc. | 2.84 % | as of Feb 28, 2026 ↗ |
| Eventide Healthcare & Life Sciences Fund MUTUAL FUND SERIES TRUST | 1.97 % | as of Mar 31, 2026 ↗ |
| State Street(R) SPDR(R) S&P(R) Pharmaceuticals ETF SPDR SERIES TRUST | 1.92 % | as of Mar 31, 2026 ↗ |
| PROFUND VP PHARMACEUTICALS ProFunds | 1.84 % | as of Mar 31, 2026 ↗ |
| Direxion Daily Pharmaceutical & Medical Bull 3X Shares Direxion Shares ETF Trust | 1.54 % | as of Apr 30, 2026 ↗ |
| PHARMACEUTICALS ULTRASECTOR PROFUND ProFunds | 1.52 % | as of Apr 30, 2026 ↗ |
| Invesco Dorsey Wright Healthcare Momentum ETF Invesco Exchange-Traded Fund Trust | 1.30 % | as of Apr 30, 2026 ↗ |
| Simplify Propel Opportunities ETF Simplify Exchange Traded Funds | 1.13 % | as of Mar 31, 2026 ↗ |
| VIFAG 2002, SICAV S.A. GESALCALA, S.A., S.G.I.I.C. | 0.86 % | as of Dec 31, 2025 ↗ |
| AMG Frontier Small Cap Growth Fund AMG Funds I | 0.80 % | as of Apr 30, 2026 ↗ |
Quarter after quarter
Each row is one quarter of SEC filings, newest first. The change compares each quarter with the one before.
| Quarter | Holders | Change | Shares | Change |
|---|---|---|---|---|
| 2026Q2 | 164 | +5 | 32,133,442 | +10.8 % |
| 2026Q1 | 159 | +19 | 28,993,137 | +28.7 % |
| 2025Q4 | 140 | +10 | 22,520,392 | +23.8 % |
| 2025Q3 | 130 | +13 | 18,194,386 | +58.5 % |
| 2025Q2 | 117 | +20 | 11,477,413 | +37.1 % |
| 2025Q1 | 97 | +7 | 8,373,898 | +13.1 % |
| 2024Q4 | 90 | +7 | 7,401,051 | +24.3 % |
| 2024Q3 | 83 | +3 | 5,954,229 | +7.5 % |
| 2024Q2 | 80 | +15 | 5,537,915 | +5.0 % |
| 2024Q1 | 65 | -8 | 5,273,683 | +9.2 % |
| 2023Q4 | 73 | 4,829,143 |
Institutional managers
190 managers declare this company to the SEC (Form 13F). The table shows the 25 largest.
| Manager | Shares | Value | |
|---|---|---|---|
| NEA Management Company, LLC | 13,222,228 | 157.7M $ | as of Mar 31, 2026 |
| BlackRock, Inc. | 10,240,186 | 122.2M $ | as of Mar 31, 2026 |
| Frazier Life Sciences Management, L.P. | 9,939,547 | 118.6M $ | as of Mar 31, 2026 |
| FMR LLC | 8,038,061 | 95.9M $ | as of Mar 31, 2026 |
| WELLINGTON MANAGEMENT GROUP LLP | 5,189,088 | 61.9M $ | as of Mar 31, 2026 |
| Vivo Capital, LLC | 5,094,668 | 60.8M $ | as of Mar 31, 2026 |
| MARSHALL WACE, LLP | 3,966,019 | 47.3M $ | as of Mar 31, 2026 |
| Rubric Capital Management LP | 3,712,373 | 44.3M $ | as of Mar 31, 2026 |
| MPM BIOIMPACT LLC | 3,298,430 | 39.4M $ | as of Mar 31, 2026 |
| VIKING GLOBAL INVESTORS LP | 3,198,644 | 38.2M $ | as of Mar 31, 2026 |
| ALLIANCEBERNSTEIN L.P. | 2,845,472 | 35.6M $ | as of Mar 31, 2026 |
| GEODE CAPITAL MANAGEMENT, LLC | 2,778,231 | 33.2M $ | as of Mar 31, 2026 |
| STATE STREET CORP | 2,665,313 | 31.8M $ | as of Mar 31, 2026 |
| EVENTIDE ASSET MANAGEMENT, LLC | 2,622,306 | 31.3M $ | as of Mar 31, 2026 |
| ORBIMED ADVISORS LLC | 2,454,400 | 29.3M $ | as of Mar 31, 2026 |
| Logos Global Management LP | 2,400,000 | 28.6M $ | as of Mar 31, 2026 |
| Vestal Point Capital, LP | 2,166,504 | 25.8M $ | as of Mar 31, 2026 |
| ACORN CAPITAL ADVISORS, LLC | 2,144,844 | 25.6M $ | as of Mar 31, 2026 |
| Artia Global Partners LP | 2,013,602 | 24M $ | as of Mar 31, 2026 |
| Affinity Asset Advisors, LLC | 2,000,172 | 23.9M $ | as of Mar 31, 2026 |
| FRONTIER CAPITAL MANAGEMENT CO LLC | 1,994,292 | 23.8M $ | as of Mar 31, 2026 |
| EMERALD ADVISERS, LLC | 1,839,566 | 21.9M $ | as of Mar 31, 2026 |
| Siren, L.L.C. | 1,786,867 | 21.3M $ | as of Mar 31, 2026 |
| Pictet Asset Management Holding SA | 1,706,048 | 20.4M $ | as of Mar 31, 2026 |
| RAYMOND JAMES FINANCIAL INC | 1,687,977 | 20.1M $ | as of Mar 31, 2026 |
Declared shareholders of Trevi Therapeutics Inc
There are 2 beneficial ownership filings. These stakes do not add up. An asset manager that files includes its own funds, which already appear among the funds on this page.
| Shareholder | Declared stake | Shares | |
|---|---|---|---|
| New Enterprise Associates 16, L.P. and 12 others | 10.50 % | 15,074,080 | as of May 5, 2026 · SCHEDULE 13D |
| FMR LLC and 1 other | 6.30 % | 8,038,061 | as of Mar 31, 2026 · SCHEDULE 13G |
Cite this page
Titelia. "Funds holding Trevi Therapeutics Inc". https://titelia.com/en/stocks/trevi-therapeutics-inc-US89532M1018